Supported by

Catalogue of collaboration profiles

back to list

Eulysis Ltd.

191 Dalkeith Road
ZIP Code
EH16 5DS
United Kingdom

Company Profile:
Based in Edinburgh, Eulysis Ltd is a device development company specialising in devices for pharmaceutical, nutritional, diagnostic and cosmetic applications. The main applications involve skin care treatments, vaccines, antibiotics, nutritional supplements, among others. Eulysis Ltd uses licensing as its business model, whereby it grants IPR rights to interested companies and collects royalties. The skin care treatments in Eulysis’ product line have been produced and sold over the past 13 years in Croatia and Greece.

Single Vial System

What we offer:
Eulysis’ area of expertise lies in device development as well as enzymatic mixing technologies. The innovative technology being offered is a single vial system through which numerous pharmaceutical, diagnostic, cosmetic and nutritional products can be delivered. For instance, in skin care treatment, the single vial system was used to compartmentalise enzymes in such a manner that they were maintained fresh and activated instantly by the consumer. This is only one of the benefits offered by our technology as opposed to the current ones available. Several other benefits include: no need for refrigeration, enhanced stability of ingredients, longer shelf life, cheaper production costs, reduced transportation and storage costs, as well as offering speed and ease of use by end consumers.

What are we looking for:
Eulysis is looking for a partner to license the technology and assume the manufacture and distribution of said technology while assuring royalty payments to Eulysis. We are looking for partners in the pharmaceutical, diagnostic, nutritional, cosmetic sectors, as our technology can be modified and adapted to fit any/all of these sectors. The partner needs to assume the manufacture and distribution of the technology as we will provide the intellectual property and know how necessary.

Collaboration sought:
  • Joint Venture Agreement
  • Licence
  • Commercial Agreement


Spyridon Tsakas

Managing Director
back to list


Enterprise Europe ScotlandAboleo LtdAccuro BiologicsAlliance BootsBeta TechnologyBitWiseFW Medical LLPInnova Partnerships LtdInterface-The knowledge connection for businessMarks and Clerk LLPMcClure Naismith LLPThe Medical Device Company LtdQuantics Consulting LtdScottish Health InnovationsPharmalinksSistemic LtdStrathclyde Institute of Medical DevicesSynthetic Nanomachines LtdTissue SolutionsUniversity of AberdeenEllis IP LtdPharmacells LtdCeltic CatalystsPharmaceutical eConsultingWeatherologyControlled TherapeuticsSphere Fluidics LimitedHighland Clinical Research FacilityMoorfields PharmaceuticalsEdinburgh Science Trianglebeocarta LtdRostiShore DesignPomBioTech GmbHIMG Innovations-Management  GmbH/ Enterprise Europe NetworkThe Eurotactics ConsultancyIBA GmbHSGS Life Science ServicesOnorach  ClinicalWideblueEnterprise Europe YorkshireAptuit ConsultingMosaigen/Endeavour CapitalEscubed LtdEulysis Ltd.Raumedic LtdCatalent Pharma SolutionsEscubed LtdUniversity of Aberdeen Research and InnovationSPRI - Basque Enterprise Europe NetworkLicentia LtdTake The WindRoslin CellabMoredun ScientificEnterprise Europe East of EnglandAvantiCell ScienceXeroshield Ltd.ImmunoSolv LimitedLeoben Research LimitedPRAXI / HELP-FORWARD Network &The Hellenic BioClusterEMBIO Diagnostics Ltd

© 2010 ConVerve GmbH | all rights reserved